News - 10 Sep `24AI Innovation: Skinopathy and VR Foundation Join Forces to Tackle Vitiligo

New

FOR IMMEDIATE RELEASE

New York, New York, September 10, 2024 – The Vitiligo Research Foundation (VR Foundation) announces a strategic partnership with Skinopathy to provide the vitiligo community with the most advanced AI technology available to dermatology patients today.

Vitiligo, an incurable autoimmune disorder affecting nearly 100 million people globally, causes progressive white skin lesions and impacts other vital organs and mental health. With misdiagnosis rates up to 40% and treatment delays common, many patients miss opportunities for effective disease management. The VR Foundation and Skinopathy aim to address these challenges through advanced tele-dermatology and AI tools.

"Skinopathy's best-in-the-class AI technology can identify common types of vitiligo from a selfie and track treatment progress, providing optimal recommendations to both dermatologists and patients," says Yan Valle, Executive Director of the VR Foundation. "We're partnering to develop the ultimate AI assistant for vitiligo."

The partnership will empower vitiligo patients through:

- Early diagnosis of new onset or relapse
- Personalized care recommendations
- Treatment monitoring via a personal journal
- Access to the latest news, clinical trials, and products

Dr. Adriana Cruz, host of the 2024 World Vitiligo Day conference, praises the technology: "It provides a holistic approach to managing a person's vitiligo journey from start to finish."

Dr. Torello Lotti, Chair of the VR Foundation's Scientific Committee, adds: "Skinopathy's platforms can significantly improve the lives of those suffering from vitiligo's psychological impact."

With over 2/3 of vitiligo patients not receiving professional treatment, the VR Foundation and Skinopathy aim to provide millions with access to cutting-edge medical technologies for better condition management.

About the Vitiligo Research Foundation:
The VR Foundation is a NYC-based non-profit dedicated to advancing vitiligo research, awareness, and support since 2010.

Website: www.vrfoundation.org

Media Contact:
Yan Valle, VR Foundation
646-327-8169
yan@vrfoundation.org

About Skinopathy:
Skinopathy is an award-winning Canadian medical AI company providing digital health tools for effective skin condition management.

Website: www.skinopathy.com

Media Contact:
Richard Pietro, Skinopathy
647-760-1540
richard@skinopathy.com